Latest News for: inflammasome

Edit

EULAR 2025 – Targeting NLRP3 Inflammasome Activation and Inflammation in Gout with NEK7 Molecular Glue Degraders: A Novel Therapeutic Strategy (Monte Rosa Therapeutics Inc)

Public Technologies 16 Jun 2025
Targeting NLRP3 Inflammasome Activation and Inflammation in Gout with NEK7 Molecular Glue Degraders ... Targeting NLRP3 Inflammasome Activation and Inflammation in Gout with NEK7 Molecular Glue Degraders ... Activation of the NLRP3 inflammasome critically.
Edit

ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1

Hastings Tribune 07 May 2025
... developments for Inflammasome ASC Inhibitor IC 100.
Edit

ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1 Agonists to Address Unmet ...

Nasdaq Globe Newswire 07 May 2025
Inflammasome inhibitors in combination with GLP-1 agonists have potential to address unmet medical needs of people living with obesity ... .
  • 1

Article Search

tools
×
×
×
×